Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Birgit Luber

3PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Aug 27, 2022
Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study.

Katharina Kolbe, Ivonne Haffner, Katrin Schierle

|Mar 03, 2020
Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines.

Elba Raimúndez, Simone Keller, Gwen Zwingenberger

|Dec 10, 2016
Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Julia Kneissl, Anja Hartmann, Nicole Pfarr

Pageof 1

Frequent Collaborators

1 joint publications

Elba Raimúndez

1 joint publications

Karolin Ebert

1 joint publications

Sabine Hug

1 joint publications

Fabian J Theis

1 joint publications

Jan Hasenauer

1 joint publications

Katharina Kolbe

1 joint publications

Ivonne Haffner

1 joint publications

Katrin Schierle

1 joint publications

Florian Lordick

Frequent Collaborators

1 joint publications

Elba Raimúndez

1 joint publications

Karolin Ebert

1 joint publications

Sabine Hug

1 joint publications

Fabian J Theis

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.7K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.5K
See more related videos

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.7K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.5K
See more related videos